Dutch DC4U and LUMC consortium receive €1.7 million Eurostars grant to jointly develop an innovative treatment of Type I diabetes

Curing diabetes with the help of sugarsImmune cell targeting restoring tolerance in type 1 diabetes mellitusABCOUDE, Netherlands, Oct. 25, 2022 /PRNewswire/ -- DC4U, a preclinical-stage immunology

Related Keywords

Netherlands ,Dresden ,Sachsen ,Germany ,Abcoude ,Utrecht ,Amsterdam ,Noord Holland ,Dutch ,Technische Universit ,Kostenloser Wertpapierhandel ,Yvette Van Kooyk ,Bart Roep ,Karsten Kretschmer ,Eurostars Sia ,Henk Vi ,Intavis Peptide Services ,Dutch National Diabetes Center ,Leiden University Medical Center ,European Commission ,Vu Medical Centre Amsterdam ,Lifespring Life Sciences Communication ,Intavis Peptide Services Gmb ,Intavis Peptide Services Gmbh ,Diabetes Type ,Chief Scientific ,Dendritic Cell Immunobiology Unit ,Centre Amsterdam ,Professor Bart Roep ,Chief Scienctific Officer ,Spinoza Prize ,Chief Executive ,Spring Life Sciences Communication ,C4u ,Umc ,Consortium ,Eceive ,Billion ,Eurostars ,Rant ,Ointly ,Evelop ,Nnovative ,Treatment ,Type ,Diabetes ,